Question 1

How does TGF-β ligand binding initiate the signaling pathway?

Accepted Answer

The dimeric TGF-β ligand binds to type II TGF-β receptors, which then recruit and phosphorylate adjacent type I receptors. This phosphorylation activates the type I receptor's serine/threonine kinase domain, forming an active tetrameric receptor complex that propagates the signal downstream through Smad protein phosphorylation.

Question 2

What role do R-Smads play in TGF-β signal transduction?

Accepted Answer

Receptor-activated Smads (R-Smads) such as Smad2 and Smad3 are phosphorylated by activated type I receptors. This phosphorylation unmasks their nuclear localization signal, allowing two R-Smads to dimerize with an unphosphorylated co-Smad like Smad4, forming a trimeric complex that translocates to the nucleus to regulate gene expression.

Question 3

How does the Smad complex regulate gene transcription in the nucleus?

Accepted Answer

The trimeric Smad complex associates with nuclear transcription factors such as TFE3 and binds to gene regulatory sequences in target genes. This binding induces gene expression and elicits appropriate cellular responses. Once the response is complete, nuclear phosphatases dephosphorylate R-Smads, causing complex disassembly and Smad translocation back to the cytosol.

Question 4

What are the three mechanisms by which inhibitory Smads downregulate TGF-β signaling?

Accepted Answer

Inhibitory Smads (I-Smads) such as Smad6 and Smad7 suppress signaling through three pathways: competing with R-Smads for receptor binding to prevent phosphorylation, recruiting Smurfs to ubiquitylate and degrade receptors, and recruiting phosphatases to dephosphorylate receptors. I-Smads also target co-Smad4 for ubiquitylation and degradation.

Question 5

How are latent TGF-β ligands activated before pathway initiation?

Accepted Answer

TGF-β ligands are synthesized in their latent form and require activation before signaling. Proteases or cell surface receptors such as integrins act upon the latent form to release the active ligand. Three mammalian TGF-β isoforms (TGF-β1, TGF-β2, and TGF-β3) bind as homodimers or heterodimers to activate the signaling pathway.

Question 6

What is the function of type III TGF-β receptors in ligand presentation?

Accepted Answer

Type III receptors (RIII) are cell-surface proteoglycans with glycosaminoglycan chains that bind TGF-β ligands first and present them to type II receptors. Alternatively, ligands may directly bind the constitutively active type II receptor. This dual mechanism ensures efficient recruitment and activation of the receptor complex.

Question 7

How does TGF-β signaling compare to other kinase receptor pathways?

Accepted Answer

TGF-β signaling uses serine/threonine kinase receptors and Smad proteins as signal transducers, distinct from receptor tyrosine kinases that activate alternative cascades. While TGF-β regulates cell proliferation and differentiation through Smad-mediated transcription, other signaling pathways like the JAK-STAT signaling pathway employ different receptor types and effector molecules for cellular responses.

TGF – szlak sygnalizacji β

Browse More Videos